Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?-Reference-Cited by-同舟云学术

Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?

Published:2016 Issue:3 Volume:69 Page:165-179
ISSN:1344-6304
Container-title:Japanese Journal of Infectious Diseases
language:en
Short-container-title:Jpn J Infect Dis

Author:

Tamura Shin-ichi¹,Ainai Akira¹,Suzuki Tadaki¹,Kurata Takeshi¹,Hasegawa Hideki¹

Affiliation:

1. Department of Pathology, National Institute of Infectious Diseases

Publisher

Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://www.jstage.jst.go.jp/article/yoken/69/3/69_JJID.2015.560/_pdf

Reference98 articles.

1. 1. Murphy BR, Webster RG. Orthomyxoviruses. In: Fields BN, Knipe DM, Howley PM, et al., editors. Fields Virology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1996. p. 1397-1445.

2. 2. Lamb RA, Krug RM. Orthomyxoviridae: The viruses and their replication. In: Fields BN, Knipe DM, Howley PM, et al., editors. Fields Virology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1996. p. 1353-95.

3. 3. Wright PF, Neumann G, Kawaoka Y. Orthomyxoviruses. In: Knipe DM, Howley PM, Griffin DE, et al., editors. Fields Virology. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006. p. 1691-1740.

4. 4. Hannoun C. The evolving history of influenza viruses and influenza vaccines. Expert Rev Vaccines 2013;12:1085-94.

5. 5. Tamura S-I, Kurata T. Defense mechanisms against influenza virus infection in the respiratory tract mucosa. Jpn J Infect Dis. 2004;57:236-47.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intranasally Inoculated SARS-CoV-2 Spike Protein Combined with Mucoadhesive Polymer Induces Broad and Long-Lasting Immunity;Vaccines;2024-07-18

2. Evaluation of the cross‐protection of the Vero cell‐derived attenuated influenza vaccines with compound adjuvant, through intranasal immunization;APMIS;2024-07-03

3. Crossprotection Induced by Virus-Like Particles Containing Influenza Dual-Hemagglutinin and M2 Ectodomain;Nanomedicine;2024-03-29

4. Systemically inoculated adjuvants stimulate pDC-dependent IgA response in local site;Mucosal Immunology;2023-06

5. Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based on the Recombinant Nucleoprotein Co-Administered with a TLR2/6 Agonist BPPcysMPEG;Pharmaceutics;2023-03-10